We are live on
!
Find out more
BA
Bennicas & Associates Portfolio holdings
AUM
$173M
1-Year Est. Return
1.55%
This Fund
S&P 500
This Quarter
Est. Return
+5.35%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
–
AUM
$129M
AUM Growth
+$9.22M
(+7.7%)
Cap. Flow
+$3.27M
Cap. Flow
% of AUM
2.53%
Top 10 Holdings %
Top 10 Hldgs %
40.83%
Holding
83
New
–
Increased
12
Reduced
26
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.74M |
| 2 |
Procter & Gamble
PG
|
+$522K |
| 3 |
Sprott Physical Gold and Silver Trust
CEF
|
+$83.6K |
| 4 |
TotalEnergies
TTE
|
+$77.8K |
| 5 |
Newmont
NEM
|
+$59.5K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$110K |
| 2 |
Copart
CPRT
|
+$62.1K |
| 3 |
Clorox
CLX
|
+$15.8K |
| 4 |
CSX Corp
CSX
|
+$14K |
| 5 |
DNP Select Income Fund
DNP
|
+$13.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 24.52% |
| 2 | Healthcare | 13.63% |
| 3 | Materials | 11.59% |
| 4 | Technology | 8.8% |
| 5 | Real Estate | 8.63% |
Similar funds
CCM
AWM
S
BFS
SCM
RCC
WWA
NEGWA
Bennicas & Associates's Q3 2019 Portfolio in Review
As of Q3 2019, Bennicas & Associates held 83 positions worth $129M, up 7.7% from $120M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 0%. Bennicas & Associates opened no new positions and made no exits, leaving the 83-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Materials.
- Bennicas & Associates added most to AbbVie in Q3 2019, an estimated $2.74M increase.
- Bennicas & Associates's biggest Q3 2019 reduction was Oracle, cutting an estimated $110K.
- Bennicas & Associates's ten largest holdings make up 41% of its $129M portfolio in Q3 2019.
- Bennicas & Associates opened 0 new positions and closed 0 in Q3 2019.
- Bennicas & Associates's portfolio value rose 7.7% quarter-over-quarter to $129M.
Based on Bennicas & Associates's 13F filing for Q3 2019, filed 7 Oct 2019.